Based on these transcriptomic changes and earlier studies, we propose that SLC-0111 may act as an epigenetic modifier activating tumor suppressor genes and downregulating oncogenes in addition to functioning as a CAIX inhibitor. Here, CA9 is linked to neoplasm.